BIOMAT Database Logo BIOMAT Database Logo

[Salicylamide in antirheumatic therapy]. 1951

C CERVINI, and G TERZANI

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012213 Rheumatic Fever A febrile disease occurring as a delayed sequela of infections with STREPTOCOCCUS PYOGENES. It is characterized by multiple focal inflammatory lesions of the connective tissue structures, such as the heart, blood vessels, and joints (POLYARTHRITIS) and brain, and by the presence of ASCHOFF BODIES in the myocardium and skin. Acute Rheumatic Fever,Arthritis, Rheumatic, Acute,Rheumatism, Articular, Acute,Arthritis, Acute Rheumatic,Inflammatory Rheumatism,Polyarthritis Rheumatica,Rheumatic Arthritis,Rheumatism, Acute Articular,Acute Articular Rheumatism,Acute Articular Rheumatisms,Acute Rheumatic Arthritides,Acute Rheumatic Arthritis,Acute Rheumatic Fevers,Arthritis, Rheumatic,Articular Rheumatism, Acute,Fever, Acute Rheumatic,Fever, Rheumatic,Fevers, Acute Rheumatic,Inflammatory Rheumatisms,Polyarthritis Rheumaticas,Rheumatic Arthritides,Rheumatic Arthritis, Acute,Rheumatic Fever, Acute,Rheumatic Fevers,Rheumatism, Inflammatory
D012457 Salicylamides Amides of salicylic acid.
D018501 Antirheumatic Agents Drugs that are used to treat RHEUMATOID ARTHRITIS. Anti-Rheumatic Agent,Anti-Rheumatic Drug,Antirheumatic Agent,Antirheumatic Disease-Modifying Second-Line Drug,Antirheumatic Drug,DMARD,Disease-Modifying Antirheumatic Drug,Disease-Modifying Antirheumatic Drugs,Anti-Rheumatic Agents,Anti-Rheumatic Agents, Non-Steroidal,Anti-Rheumatic Drugs,Antirheumatic Disease-Modifying Second-Line Drugs,Antirheumatic Drugs,Antirheumatic Drugs, Disease-Modifying,Disease-Modifying, Antirheumatic Second-Line Drugs,Agent, Anti-Rheumatic,Agent, Antirheumatic,Anti Rheumatic Agent,Anti Rheumatic Agents,Anti Rheumatic Agents, Non Steroidal,Anti Rheumatic Drug,Anti Rheumatic Drugs,Antirheumatic Disease Modifying Second Line Drug,Antirheumatic Disease Modifying Second Line Drugs,Antirheumatic Drug, Disease-Modifying,Antirheumatic Drugs, Disease Modifying,Disease Modifying Antirheumatic Drug,Disease Modifying Antirheumatic Drugs,Disease Modifying, Antirheumatic Second Line Drugs,Drug, Anti-Rheumatic,Drug, Antirheumatic,Drug, Disease-Modifying Antirheumatic,Non-Steroidal Anti-Rheumatic Agents

Related Publications

C CERVINI, and G TERZANI
[Parenteral salicylamide therapy].
February 1954, Therapie der Gegenwart,
C CERVINI, and G TERZANI
[Salicylamide as an analgesic and antirheumatic; results of a two year test].
March 1953, Medizinische Monatsschrift,
C CERVINI, and G TERZANI
Antirheumatic therapy.
April 1979, The Medical journal of Australia,
C CERVINI, and G TERZANI
[Intravenous salicylamide therapy in rheumatic diseases].
April 1953, Munchener medizinische Wochenschrift (1950),
C CERVINI, and G TERZANI
[Intravenous salicylamide therapy in neurological practice].
October 1953, Deutsche medizinische Wochenschrift (1946),
C CERVINI, and G TERZANI
New directions in antirheumatic therapy.
August 1989, Rheumatic diseases clinics of North America,
C CERVINI, and G TERZANI
[Pyrimidone gentisate in antirheumatic therapy].
April 1953, Clinica nuova; rassegna del progresso medico internazionale,
C CERVINI, and G TERZANI
[Digestive repercussions in antirheumatic drug therapy].
January 1977, Revista espanola de las enfermedades del aparato digestivo,
C CERVINI, and G TERZANI
[Modern acquisitions in antirheumatic therapy; prednisone].
December 1955, El Dia medico,
C CERVINI, and G TERZANI
Disease controlling antirheumatic therapy in spondyloarthropathy.
June 2001, The Journal of rheumatology. Supplement,
Copied contents to your clipboard!